Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 521

Sort by

Sort Order Select

Journal Articles

2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party

Blood blood.2025031480.

https://doi.org/10.1182/blood.2025031480

Published: 2025

Includes: Supplemental data

Journal Articles

CLL with t(11;14)(q13;q32) or t(14:18)(q32:q21) – is this CLL or lymphoma?

Alessandro Baldi, Wencke Walter, Anna Stengel, Heiko Mueller, Manja Meggendorfer, Isolde Summerer, Wolfgang Kern, Veronika Ecker

Blood (2025) 146 (Supplement 1): 2114.

https://doi.org/10.1182/blood-2025-2114

Published: 2025

Journal Articles

Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis

Wencke Walter, Sarah Keppler, Veronika Ecker, Wolfgang Kern, Torsten Haferlach, Anna Stengel

Blood (2025) 146 (Supplement 1): 339.

https://doi.org/10.1182/blood-2025-339

Published: 2025

Journal Articles

Automated multi-source data consensus classification of low-frequency variants in hematologic malignancies using transparent artificial intelligence

Niroshan Nadarajah, Nanditha Mallesh, Kathrin Hildebrand, Wolfgang Kern, Torsten Haferlach

Blood (2025) 146 (Supplement 1): 2576.

https://doi.org/10.1182/blood-2025-2576

Published: 2025

Journal Articles

The rearrangement partner and the presence of MYC mutations determines outcome of patients with MYC and BCL6 rearrangements

Anna Stengel, Miriam Lenk, Wolfgang Kern, Wencke Walter

Blood (2025) 146 (Supplement 1): 1749.

https://doi.org/10.1182/blood-2025-1749

Published: 2025

Journal Articles

Enrichment of rare pathogenic variants in common cancer predisposition genes in lymphatic malignancy: A comprehensive analysis of 2,138 cases

Lea Dewi Schlieben, Torsten Haferlach, Wolfgang Kern, Manja Meggendorfer, Armin Piehler

Blood (2025) 146 (Supplement 1): 1767.

https://doi.org/10.1182/blood-2025-1767

Published: 2025

Journal Articles

Immune-based risk score derived from bulk and single-cell transcriptomics enhances prognostic stratification in MDS

Blood (2025) 146 (Supplement 1): 115.

https://doi.org/10.1182/blood-2025-115

Published: 2025

Journal Articles

Determining the origin of TP53 mutations in patients with mature B-cell neoplasms is essential to distinguish lymphoma-related mutations from those due to clonal hematopoiesis, helping to guide treatment decisions

Veronika Ecker, Wencke Walter, Martha-Lena Mueller, Nicola Goetz, Christiane Eder, Manja Meggendorfer, Sandra Huber, Jana Wobst, Wolfgang Kern, Gregor Hoermann

Blood (2025) 146 (Supplement 1): 5389.

https://doi.org/10.1182/blood-2025-5389

Published: 2025

Journal Articles

Automated AI classification in clinical flow cytometry: Transforming B-cell lymphoma diagnostics

Chrysanthi Tsamadou, Sven Maschek, Lisa Erdl, Nanditha Mallesh, Miriam Lenk, Martha-Lena Mueller, Christian Pohlkamp, Wolfgang Kern

Blood (2025) 146 (Supplement 1): 6122.

https://doi.org/10.1182/blood-2025-6122

Published: 2025

Journal Articles

ML-driven analysis of iscn karyotypes enables detection of novel prognostic markers in chronic lymphocytic leukemia (CLL)

Ilaria Looser, Anna Stengel, Isolde Summerer, Matthias Heinig, Carsten Marr, Wolfgang Kern, Alessandro Baldi

Blood (2025) 146 (Supplement 1): 6118.

https://doi.org/10.1182/blood-2025-6118

Published: 2025

Journal Articles

Long-read single-cell isoform sequencing for cell type-specific detection of genomic rearrangement-dependent and -independent fusion transcripts

Wencke Walter, Wolfgang Kern, Anna Stengel

Blood (2025) 146 (Supplement 1): 6117.

https://doi.org/10.1182/blood-2025-6117

Published: 2025

Journal Articles

Additional genetic targets are present in the majority of AML patients with NPM1, KMT2A or NUP98 aberrations potentially impacting combination therapy with menin inhibitors

Rainer Ordemann, Sandra Huber, Alessandro Baldi, Anna Stengel, Irene Fuhrmann, Christian Pohlkamp, Manja Meggendorfer, Sabit Delic, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann

Blood (2025) 146 (Supplement 1): 5248.

https://doi.org/10.1182/blood-2025-5248

Published: 2025

Journal Articles

Determining telomere content and genomics of myeloid neoplasia by whole-genome sequencing

Blood blood.2025028644.

https://doi.org/10.1182/blood.2025028644

Published: 2025

Includes: Supplemental data

Journal Articles

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Anetta Marcinek, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2024-204966

Published: 2024

Journal Articles

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

Claudia Haferlach, Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach

Blood (2024) 144 (Supplement 1): 1836.

https://doi.org/10.1182/blood-2024-201270

Published: 2024

Journal Articles

A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)

Luca Lanino, Anthony M. Hunter, Nico Gagelmann, Marie Robin, Claudia Sala, Daniele Dall'Olio, Carmelo Gurnari, Lorenzo Dall'Olio, Yu-Hung Wang, Lisa Pleyer, Blanca Xicoy, Guillermo Montalban-Bravo, Lee-Yung Shih, Tamanna Haque, Omar Abdel-Wahab, Klaus Geissler, Alex Bataller, Alexandre Bazinet, Manja Meggendorfer, Ilaria Carola Casetti, Elisabetta Sauta, Erica Travaglino, Laura Palomo, Lurdes Zamora, David Quintela, Andres Jerez, Elena Cornejo, Paloma Garcia Martin, Marina Díaz-Beyá, Alejandro Avendaño Pita, Veronica Roldan, Dolly Viviana Fiallo Suarez, Estefania Cerezo Velasco, Marisa Calabuig, Esperanza Such, Guillermo Sanz, Anne Sophie Kubasch, Cristina Castilla-Llorente, Claude-Éric Bulabois, Laetitia Souchet, Hussein Awada, Massimo Bernardi, Patrizia Chiusolo, Antonio Curti, Luisa Giaccone, Francesco Onida, Lorenza Maria Borin, Francesco Passamonti, Elisa Diral, Vladan Vucinic, Gregorio Maria Bergonzi, Maria Teresa Voso, Hsin-An Hou, Wen-Chien Chou, Chi-Yuan Yao, Chien-Chin Lin, Hwei-Fang Tien, Alessia Campagna, Marta Ubezio, Antonio Russo, Gabriele Todisco, Giulia Maggioni, Cristina Astrid Tentori, Alessandro Buizza, Gianluca Asti, Matteo Zampini, Elena Riva, Mattia Delleani, Angela Consagra, Francesca Ficara, Armando Santoro, Luciana Carota, Tiziana Sanavia, Cesare Rollo, Ahmad Kiwan, Jennifer VanOudenhove, Piero Fariselli, Najla H. Al Ali, David Sallman, Wolfgang Kern, Guillermo Garcia-Manero, Swapna Thota, Elizabeth A. Griffiths, Matilde Yung Follo, Carlo Finelli, Uwe Platzbecker, Francesc Sole, Maria Diez-Campelo, Jaroslaw Maciejewski, Rafael Bejar, Felicitas R. Thol, Nicolaus Kröger, Pierre Fenaux, Raphael Itzykson, Timothy Aaron Graubert, Michaela Fontenay, Amer M. Zeidan, Rami S. Komrokji, Valeria Santini, Torsten Haferlach, Ulrich Germing, Saverio D'Amico, Gastone Castellani, Mrinal M. Patnaik, Eric Solary, Eric Padron, Matteo Giovanni Della Porta

Blood (2024) 144 (Supplement 1): 1003.

https://doi.org/10.1182/blood-2024-200104

Published: 2024

Journal Articles

Subtype Classification of BCP-ALL Dic(9;20)

Wencke Walter, Anna Stengel, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 5914.

https://doi.org/10.1182/blood-2024-204542

Published: 2024

Journal Articles

Mutational Landscape of SH2B3 -Mutated Hematologic Malignancies

Natalie Wossidlo, Khalid Shoumariyeh, Constance Regina Baer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Manja Meggendorfer

Blood (2024) 144 (Supplement 1): 6689.

https://doi.org/10.1182/blood-2024-205394

Published: 2024

Journal Articles

Similarities and Differences of DNMT3A , TET2 and ASXL1 Mutations across Ccus, MDS and AML

Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2024-200561

Published: 2024

Journal Articles

Telomere Content Diversity in Myeloid Neoplasia Could Inform on Differential Sensitivity to Telomerase Inhibitors

Blood (2024) 144 (Supplement 1): 4104.

https://doi.org/10.1182/blood-2024-209923

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party

CLL with t(11;14)(q13;q32) or t(14:18)(q32:q21) – is this CLL or lymphoma?

Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis

Automated multi-source data consensus classification of low-frequency variants in hematologic malignancies using transparent artificial intelligence

The rearrangement partner and the presence of MYC mutations determines outcome of patients with MYC and BCL6 rearrangements

Enrichment of rare pathogenic variants in common cancer predisposition genes in lymphatic malignancy: A comprehensive analysis of 2,138 cases

Immune-based risk score derived from bulk and single-cell transcriptomics enhances prognostic stratification in MDS

Determining the origin of TP53 mutations in patients with mature B-cell neoplasms is essential to distinguish lymphoma-related mutations from those due to clonal hematopoiesis, helping to guide treatment decisions

Automated AI classification in clinical flow cytometry: Transforming B-cell lymphoma diagnostics

ML-driven analysis of iscn karyotypes enables detection of novel prognostic markers in chronic lymphocytic leukemia (CLL)

Long-read single-cell isoform sequencing for cell type-specific detection of genomic rearrangement-dependent and -independent fusion transcripts

Additional genetic targets are present in the majority of AML patients with NPM1, KMT2A or NUP98 aberrations potentially impacting combination therapy with menin inhibitors

Determining telomere content and genomics of myeloid neoplasia by whole-genome sequencing

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)

Subtype Classification of BCP-ALL Dic(9;20)

Mutational Landscape of SH2B3 -Mutated Hematologic Malignancies

Similarities and Differences of DNMT3A , TET2 and ASXL1 Mutations across Ccus, MDS and AML

Telomere Content Diversity in Myeloid Neoplasia Could Inform on Differential Sensitivity to Telomerase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only